Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Ambrosia Biosciences is a biotechnology company focused on developing orally delivered, small molecule therapies for obesity and metabolic disorders. Leveraging advanced structural biology, AI-driven molecular design, and integrated chemistry and biology platforms, the company accelerates drug discovery from hit identification to IND. With deep expertise in GPCR-targeted therapeutics and a strong scientific track record, Ambro...
Ambrosia Biosciences is a biotechnology company focused on developing orally delivered, small molecule therapies for obesity and metabolic disorders. Leveraging advanced structural biology, AI-driven molecular design, and integrated chemistry and biology platforms, the company accelerates drug discovery from hit identification to IND. With deep expertise in GPCR-targeted therapeutics and a strong scientific track record, Ambrosia aims to deliver safe, effective, and scalable treatments for cardiometabolic diseases.

List your booth number for exhibitions, ask us